Nonprofit · EIN 46-4072112
SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK
Tax-exempt · PORTLAND, OR 97238
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| September 30, 2025 | 990 | $62,180 | $397,610 | -$335,430 | $3,912,478 | $0 | $3,912,478 |
| July 31, 2024 | 990 | $669,112 | $598,008 | $71,104 | $2,444,182 | $159,653 | $2,284,529 |
| July 31, 2023 | 990 | $1,072,855 | $820,283 | $252,572 | $3,043,861 | $201,874 | $2,841,987 |
Financial details: 990 for the year ended September 30, 2025
Revenue
- Contributions, gifts and grants
- $55,135
- Program service revenue
- $0
- Investment income
- $7,045
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $310,000
- Compensation of officers, directors and key employees
- $25,650
- Salaries, compensation and benefits (total)
- $25,650
- Professional fundraising fees
- $0
- Program services (functional)
- $396,010
- Management and general (functional)
- $1,600
Balance sheet and other
- Total assets, start of year
- $4,059,121
- Total assets, end of year
- $3,912,478
- Total liabilities, end of year
- $0
- Net assets, end of year
- $3,912,478
- Publicly traded securities
- $2,802,343
- Net assets without donor restrictions
- $3,912,478
- Gross receipts
- $62,180
- Employees
- 0
- Volunteers
- 40
- Year formed
- 2013
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended September 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| MATTHEW STOLL PHD MD | CHAIR Trustee or director, Officer | 10 | $0 |
| JOERG ERMANN MD | IMMEDIATE PAST CHAIR Trustee or director, Officer | 3 | $0 |
| IGNACIO GARCIA-VALLARDES MD | DIRECTOR Trustee or director | 2 | $0 |
| SIBA RAYCHAUDHURI MD | DIRECTOR Trustee or director | 2 | $0 |
| MAUREEN DUBREUIL MD | TREASURER, VICE-CHAIR Trustee or director, Officer | 2 | $0 |
| NIGIL HAROON PHD MD | VICE-CHAIR Trustee or director, Officer | 3 | $0 |
| JEAN LIEW MD MSC | DIRECTOR Trustee or director | 3 | $0 |
| MARINA MAGREY MD | SECRETARY Trustee or director, Officer | 2 | $0 |
| JOHN REVEILLE MD | DIRECTOR Trustee or director | 2 | $0 |
| MOHAMAD BITTAR MD | DIRECTOR Trustee or director | 3 | $0 |
| AKIHIRO NAKAMURA MD PHD | DIRECTOR Trustee or director | 2 | $0 |
| LISA SPIEGEL | EXECUTIVE DIRECTOR Officer | 30 | $0 |
990 for the year ended July 31, 2024: 12 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| LISA SPIEGEL | EXECUTIVE DIRECTOR Officer | 30 | $106,300 |
| MATTHEW STOLL PHD MD | CHAIR Trustee or director, Officer | 10 | $0 |
| JOERG ERMANN MD | IMMEDIATE PAST CHAIR Trustee or director, Officer | 3 | $0 |
| IGNACIO GARCIA-VALLARDES MD | DIRECTOR Trustee or director, Officer | 2 | $0 |
| SIBA RAYCHAUDHURI MD | DIRECTOR Trustee or director | 2 | $0 |
| MAUREEN DUBREUIL MD | TREASURER Trustee or director, Officer | 2 | $0 |
| NIGIL HAROON PHD MD | VICE-CHAIR Trustee or director, Officer | 3 | $0 |
| JEAN LIEW MD MSC | DIRECTOR Trustee or director | 3 | $0 |
| MARINA MAGREY MD | SECRETARY Trustee or director, Officer | 2 | $0 |
| JOHN REVEILLE MD | DIRECTOR Trustee or director | 2 | $0 |
| MOHAMAD BITTAR MD | DIRECTOR Trustee or director | 3 | $0 |
| AKIHIRO NAKAMURA MD PHD | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended July 31, 2023: 11 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| LISA SPIEGEL | EXECUTIVE DIRECTOR Officer | 40 | $107,412 |
| MATTHEW STOLL PHD MD | TREASURER Trustee or director, Officer | 4 | $0 |
| JOERG ERMANN MD | CHAIR Trustee or director, Officer | 10 | $0 |
| JUDITH SMITH PHD MD | PAST CHAIR Trustee or director, Officer | 2 | $0 |
| SIBA RAYCHAUDHURI MD | DIRECTOR Trustee or director | 1 | $0 |
| MAUREEN DUBREUIL MD | DIRECTOR Trustee or director | 3 | $0 |
| NIGIL HAROON PHD MD | DIRECTOR Trustee or director | 3 | $0 |
| WALTER MAKSYMOWYCH MD | SECRETARY Trustee or director, Officer | 3 | $0 |
| MARINA MAGREY MD | DIRECTOR Trustee or director | 3 | $0 |
| JOHN REVEILLE MD | DIRECTOR Trustee or director | 3 | $0 |
| RUNSHENG WANG MD | DIRECTOR Trustee or director | 3 | $0 |
Address and contacts
- Address (IRS master file)
- PO BOX 55491, PORTLAND, OR 97238-5491
- In care of
- % JOHN D REVEILLE
- Principal officer (990 for 2025)
- MAUREEN DUBREUIL MD, PO BOX 55491, PORTLAND, OR 97238
- Signed the 990
- MAUREEN DUBREUIL MD, TREASURER, VICE CHAIR
- Phone
- (360) 600-2170
- Website
- WWW.SPARTANGROUP.ORG
- Return prepared by
- QUIGLEY & MIRON
Mission
THE MISSION OF SPARTAN IS TO FOSTER RESEARCH AND EDUCATION IN SPONDYLOARTHRITIS IN THE UNITED STATES. SPARTAN MEMBERS ACCOMPLISH THIS MISSION BY ENGAGING IN SPECIFIC RESEARCH PROJECTS AND THROUGH AN ANNUAL MEETING, WHICH HIGHLIGHTS IMPORTANT EDUCATION AND RESEARCH PROGRAMS.
Program accomplishments
- SPARTAN ANNUAL MEETINGSPARTAN HOLDS AN ANNUAL MEETING TO HIGHLIGHT ADVANCES IN SPONDYLOARTHRITIS RESEARCH AND TREATMENT AND ENCOURAGE POST-DOCTORAL FELLOWS TO ENGAGE IN THE SPARTAN MISSION OF FOSTERING RESEARCH AND EDUCATION IN THE FIELD OF SPONDYLOARTHRITIS (SPA). THE RESEARCH AND EDUCATION MEETING IS ALSO AN OPPORTUNITY TO BRING TOGETHER EXPERT, DEDICATED RESEARCHERS TO IDENTIFY AND ADDRESS UNMET NEEDS IN THE FIELD OF SPA RESEARCH AND THERAPY. PRESENTERS IN THE SCIENTIFIC SESSIONS ARE THE PROMINENT INTERNATIONAL EXPERTS IN THEIR FIELDS. THE SPONDYLOARTHRITIS REVIEW COURSE IS A PRE-MEETING WORKSHOP FOR RHEUMATOLOGY FELLOWS, APPS, AND OTHER TRAINEES. WE CONDUCTED AN ULTRASOUND WORKSHOP ATTENDED BY MORE THAN 75 LEARNERS.SPARTAN RESEARCH PROJECTSBASIS (BIOMARKERS IN AXIAL SPONDYLOARTHRITIS INVESTIGATIVE STUDY) THE PRIMARY OBJECTIVE IS TO ESTABLISH A WELL-CHARACTERIZED BIOBANK FOR AXSPA AND IDENTIFY A DIAGNOSTIC BIOMARKER(S) UTILIZING A CROSS-SECTIONAL STUDY OF INDIVIDUALS WITHIN THE SPECTRUM OF AXSPA. THE BASIS STEERING COMMITTEE IS COLLABORATING WITH INDUSTRY PARTNERS AND INTENDS TO LAUNCH THE PROGRAM IN 2025.Expenses $86,010
- SPARTAN GRANTSTHE MISSION OF SPARTAN IS TO ADVANCE RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH SPONDYLOARTHRITIS. WE FEEL STRONGLY THAT LAYING THE FOUNDATION FOR THE NEXT GENERATION OF RESEARCHERS AND LEADERS IN SPA IS AN IMPORTANT PORTAL TO ACHIEVE THIS MISSION. THE GOAL OF OUR GRANT PROGRAMS IS TO SUPPORT THE EARLY STAGES OF A FELLOW-LED RESEARCH PROJECT. WITH THE AIM OF ENCOURAGING FELLOWS TO TAKE UP RESEARCH PROJECTS UNDER MENTORS WITH EXPERTISE IN SPA, SPARTAN SUPPORTS TO 2 MENTORED FELLOWSHIP PROJECTS EACH YEAR ($10,000 PER PROJECT WITH $5,000 EACH FOR THE MENTOR AND MENTEE). SPARTAN'S EARLY CAREER INVESTIGATOR AWARD SUPPORTS EARLY CAREER INVESTIGATORS WHO ARE WORKING IN THE FIELD OF AXIAL SPONDYLOARTHRITIS AND HAS BEEN RENAMED THE EARLY CAREER INVESTIGATOR (ECI) AWARD WITH UP TO 2 NEW GRANTS SUPPORTED ($25,000 PER PROJECT PER YEAR FOR TWO YEARS) ANNUALLY. TRAVEL AWARDS GO TO THE TOP 3 ABSTRACTS TO SUPPORT TRAVEL TO INDUSTRY MEETINGS (3 AWARDS @ $1,000 EACH).Expenses $310,000 · grants $310,000
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | September 30, 2026 | February 16, 2027 | Not due yet |
| 2024 | September 30, 2025 | February 17, 2026 | 990 on file |
| 2023 | September 30, 2024 | February 18, 2025 | Check at the IRS |
IRS record
- EIN
- 46-4072112
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2015
- Accounting year ends
- September
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G51)
- Assets (IRS master file)
- $3,912,478
- Income (IRS master file)
- $62,180
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | September 2025 | $62,180 | $397,610 | $3,912,478 | XML |
| 990 | July 2024 | $669,112 | $598,008 | $2,444,182 | XML |
| 990 | July 2023 | $1,072,855 | $820,283 | $3,043,861 | XML |
| 990 | July 2022 | $1,197,948 | $2,108,521 | $2,490,686 | IRS |
| 990 | July 2021 | – | – | – | IRS |
| 990 | July 2020 | – | – | – | IRS |
| 990 | July 2019 | – | – | – | IRS |
| 990 | July 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-4072112).
Questions about SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK
- What is the EIN of SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK?
- The employer identification number (EIN) of SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK is 46-4072112.
- Is SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2015.
- Are donations to SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK due?
- The return for tax year 2025 (the year ending September 30, 2026) is due February 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended September 2025.
- Who is the principal officer of SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK?
- The 990 for the year ended September 30, 2025 names MAUREEN DUBREUIL MD.
- Who are the officers and directors of SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK?
- The 990 for the year ended September 30, 2025 lists 12 people; 0 received compensation from the organization.
- How much revenue does SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK have?
- On its 990 for the year ended September 30, 2025 it reported revenue of $62,180, expenses of $397,610 and total assets of $3,912,478 at year end.
Other nonprofits in PORTLAND
- CASCADE AIDS PROJECT EIN 93-0903383 · last filed 990 for 2025
- UNITED CEREBRAL PALSY ASSOC OF OREG ON AND SOUTHWEST WASHINGTON INC EIN 93-0462580 · last filed 990 for 2025
- HOUSECALL PROVIDERS PC EIN 82-1663503 · last filed 990 for 2024
- PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE INC EIN 84-2173231 · last filed 990 for 2025
- OREGON LIONS SIGHT AND HEARING FOUNDATION INC EIN 93-6041506 · last filed 990 for 2025
- ESTUARY CENTER EIN 87-4446339 · last filed 990 for 2025
- THE BLOSSER CENTER FOR DYSLEXIA RESOURCES EIN 93-1319640 · last filed 990 for 2025
- BRIAN GRANT FOUNDATION EIN 27-1628944 · last filed 990 for 2025
All nonprofits in PORTLAND · Oregon · Voluntary health associations and medical disciplines